Delivery Order SPE2DB22D3011-SPE2DB25FQ1WT
Award Date 7/21/25
Potential Completion Date 7/22/25
Potential Value $18K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of OZEMPIC 2 MG/DOSE (8 MG/3 ML) 3ML, a medication used for the treatment of diabetes. The contract has a ceiling value of $7,783.13 and an ultimate completion date of February 11, 2025. The contract was awarded on February 10, 2025 and does not have a set-aside...
- This is a $19,596.36 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order is for OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML, a medication used to manage diabetes. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at three thousand forty-one dollars and four cents ($3,041.04) by the Defense Logistics Agency Troop Support Medical to provide OZEMPIC 2 MG/DOSE (8 MG/3 ML) 3ML. The order was awarded on December 11, 2023 and is to be completed by December 12, 2023. No set-aside designation was applied to this procurement. The delivery order was issued against DMS Pharmaceutical Group's indefinite delivery contract with...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OZEMPIC 2 MG/DOSE (8 MG/3 ML) 3ML, a diabetes medication. The contract has a ceiling value of $4,872.97 and a period of performance ending on May 13, 2025. This award is not designated as a set-aside contract, indicating open competition. The contract is part of...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at one thousand, nine hundred thirty-five dollars and twenty-four cents ($1,935.24) by the Defense Logistics Agency Troop Support Medical to provide OZEMPIC 2 MG/DOSE (8 MG/3 ML) 3ML. The delivery order was awarded on November 2, 2023 under DMS Pharmaceutical Group's indefinite delivery contract with the Defense Logistics Agency, which has a potential value of up to five million dollars through December 2025....
- This is a $4,501.67 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a division of Amerisourcebergen Corporation. The contract is for the supply of OZEMPIC 2 MG/DOSE (8 MG/3 ML) 3ML, a prescription medication. The contract does not have a set-aside designation and has an ultimate completion date of May 15, 2024. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a $3,165.31 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML, a medication used for the treatment of diabetes. The contract has an ultimate completion date of December 20, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA...
- This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $20,540.71, is for the delivery of OZEMPIC 2 MG/DOSE (8 MG/3 ML) 3ML, a medication used for the treatment of diabetes. The contract has a performance period ending on March 28, 2025. This contract is not designated as a set-aside, indicating open competition. AmerisourceBergen...
- This is a $11,234.40 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of OZEMPIC 2 MG/DOSE (8 MG/3 ML) 3ML, a medication used for diabetes management. The contract has an ultimate completion date of January 5, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...
- This is a $63,557.72 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of OZEMPIC 2 MG/DOSE (8 MG/3 ML) 3ML. The contract has an ultimate completion date of July 17, 2025 and does not utilize a set-aside designation. The contract is part of AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00 and running through December 2026. This...